Patents by Inventor Wei Dang

Wei Dang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12180303
    Abstract: Disclosed are an antibody that can bind to human MASP-2, a preparation method therefor and an application thereof. The anti-human MASP-2 antibody of the present invention can specifically bind to human MASP-2, has good biological activity of inhibiting the cleavage of C4 and the generation of C3b, and can be applied in the treatment of MASP-2 related diseases, such as IgA nephropathy.
    Type: Grant
    Filed: October 13, 2023
    Date of Patent: December 31, 2024
    Assignee: SHANGHAI MABGEEK BIOTECH. CO., LTD.
    Inventors: Yipan Wu, Wei Dang, Chenghai Zhang, Lingqiao Zhu, Jinlin Guo, Yujing Yuan, Qiuling Zou, Yang Wang, Shun Hu
  • Publication number: 20240300832
    Abstract: An oil-water mixture treatment device has a laminar separator and an electric field separator. The laminar separator has a coalescing tube with coalescing filler provided therein, a separating tube arranged above the coalescing tube, and a discharging tube arranged above the separating tube. The coalescing tube is connected to said separating tube by a first connecting tube group and the separating tube is connected to the discharging tube by a second connecting tube group. The oil-water mixture to be treated enters, after being treated in the coalescing tube, the separating tube through the first connecting tube group for laminar separation. The resulting oil phase enters the discharging tube through the second connecting tube group and then is discharged through an oil discharge pipeline, while the resulting water phase enters the electric field separator from a lower portion of the separating tube for a next stage of separation.
    Type: Application
    Filed: September 29, 2021
    Publication date: September 12, 2024
    Inventors: Lili WANG, Wei DANG, Pengyuan DING, Changchao HU, Caixia BI, Zhiwei TANG, Wenjie TAN, Xingwang WANG, Yanxiao SI
  • Publication number: 20240262904
    Abstract: Disclosed in the present invention are an antibody capable of binding to human thymic stromal lymphopoietin (hTSLP), a preparation method therefor and an application thereof. The anti-hTSLP antibody of the present invention can specifically bind to a hTSLP receptor, has a good effect of inhibiting the secretion of TARC by PBMC, and can be applied to the treatment of TSLP-related diseases, such as immune-mediated inflammatory diseases.
    Type: Application
    Filed: October 19, 2021
    Publication date: August 8, 2024
    Inventors: Jinlin GUO, Yujing YUAN, Wei DANG, Yipan WU, Lingqiao ZHU, Chenghai ZHANG, Qiuling ZOU, Zhike LI, Yang WANG
  • Publication number: 20240043563
    Abstract: Disclosed are an antibody that can bind to human MASP-2, a preparation method therefor and an application thereof. The anti-human MASP-2 antibody of the present invention can specifically bind to human MASP-2, has good biological activity of inhibiting the cleavage of C4 and the generation of C3b, and can be applied in the treatment of MASP-2 related diseases, such as IgA nephropathy.
    Type: Application
    Filed: October 13, 2023
    Publication date: February 8, 2024
    Inventors: Yipan WU, Wei DANG, Chenghai ZHANG, Lingqiao ZHU, Jinlin GUO, Yujing YUAN, Qiuling ZOU, Yang WANG, Shun HU
  • Publication number: 20240026023
    Abstract: The present invention relates to Fc variants having decreased affinity for Fc?RIIb, methods for their generation, Fc polypeptides comprising optimized Fc variants, and methods for using optimized Fc variants.
    Type: Application
    Filed: August 25, 2023
    Publication date: January 25, 2024
    Inventors: Gregory Lazar, Wei Dang, John Desjarlais, Sher Karki, Omid Vafa, Robert Hayes, Jost Vielmetter
  • Patent number: 11874211
    Abstract: A method and device for obtaining microscopic occurrence characteristics of oil stored in a shale, where the microscopic occurrence characteristics include the adsorbed oil film thicknesses in the shale and the oil distribution in the shale. The method includes four steps. The first step is an experiment step in which a N-Hexane vapor adsorption experiment is performed on a sample made from a shale. The second step is a first obtaining step for calculating and obtaining the adsorbed oil film thicknesses in the shale. The third step is a first calculating step and the fourth step is a second obtaining step. They aim to obtain the oil distribution in the shale.
    Type: Grant
    Filed: October 27, 2022
    Date of Patent: January 16, 2024
    Assignee: Xi'An Shiyou University
    Inventors: Wei Dang, Xiaoliang Wei
  • Patent number: 11820830
    Abstract: The present invention relates to Fc variants having decreased affinity for Fc?RIIb, methods for their generation, Fc polypeptides comprising optimized Fc variants, and methods for using optimized Fc variants.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: November 21, 2023
    Assignee: Xencor, Inc.
    Inventors: Gregory Lazar, Wei Dang, John Desjarlais, Sher Karki, Omid Vafa, Robert Hayes, Jost Vielmetter
  • Publication number: 20230330563
    Abstract: An oil-water separation apparatus has a housing that contains at least one longitudinal plate member arranged in a longitudinal direction of the housing (10) and inclined relative to a horizontal direction. The longitudinal plate member forms at least one fluid channel in an inner chamber of the housing. A first guiding hole is provided on the longitudinal plate member or between the longitudinal plate member and an inner wall of the housing, and is in communication with the fluid channel. A second guiding hole is provided on the longitudinal plate member or between the longitudinal plate member and the inner wall of the housing, and is in communication with the fluid channel and is placed lower than the first guiding hole is positioned. A collection pipe is arranged at a longitudinal downstream end of the housing, and is in communication with the inner chamber of the housing.
    Type: Application
    Filed: October 30, 2020
    Publication date: October 19, 2023
    Inventors: Changchao HU, Xiaoxuan XU, Wei DANG, Pengyuan DING, Xingwang WANG, Zhiwei TANG, Wenjie TAN, Lili WANG, Yanxiao SI, Caixia BI
  • Publication number: 20230146357
    Abstract: A method and device for obtaining microscopic occurrence characteristics of oil stored in a shale, where the microscopic occurrence characteristics include the adsorbed oil film thicknesses in the shale and the oil distribution in the shale. The method includes four steps. The first step is an experiment step in which a N-Hexane vapor adsorption experiment is performed on a sample made from a shale. The second step is a first obtaining step for calculating and obtaining the adsorbed oil film thicknesses in the shale. The third step is a first calculating step and the fourth step is a second obtaining step. They aim to obtain the oil distribution in the shale.
    Type: Application
    Filed: October 27, 2022
    Publication date: May 11, 2023
    Inventors: Wei Dang, Xiaoliang Wei
  • Patent number: 11254746
    Abstract: An anti-human PD-1 monoclonal antibody, and a preparation method therefor and an application thereof. The anti-human PD-1 monoclonal antibody has good bioactivity, can effectively bind with an extracellular region of a human PD-1 protein receptor, and can effectively seal PD-1 protein at protein level and cellular level and block the binding of the PD-1 protein with a ligand PD-L1, thereby effectively enhancing immunity. The monoclonal antibody can be applied independently or jointly with other antitumor drugs to tumor immunotherapy and the diagnosis and screening of patients with PD-L1 positive tumors; and the monoclonal antibody has a promising prospect in the preparation of drugs for treating tumors, resisting autoimmune diseases and the like.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: February 22, 2022
    Assignee: SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LT
    Inventors: Jie Zhao, Honghai Gao, Jinlin Guo, Wei Dang, Lingqiao Zhu, Chenghai Zhang, Le Zhao, Jianhe Chen, Haomin Huang, Zhenping Zhu
  • Publication number: 20210139600
    Abstract: The present invention relates to Fc variants having decreased affinity for Fc?RIIb, methods for their generation, Fc polypeptides comprising optimized Fc variants, and methods for using optimized Fc variants.
    Type: Application
    Filed: July 29, 2020
    Publication date: May 13, 2021
    Inventors: Gregory Lazar, Wei Dang, John Desjarlais, Sher Karki, Omid Vafa, Robert Hayes, Jost Vielmetter
  • Publication number: 20200377597
    Abstract: An anti-human PD-1 monoclonal antibody, and a preparation method therefor and an application thereof. The anti-human PD-1 monoclonal antibody has good bioactivity, can effectively bind with an extracellular region of a human PD-1 protein receptor, and can effectively seal PD-1 protein at protein level and cellular level and block the binding of the PD-1 protein with a ligand PD-L1, thereby effectively enhancing immunity. The monoclonal antibody can be applied independently or jointly with other antitumor drugs to tumor immunotherapy and the diagnosis and screening of patients with PD-L1 positive tumors; and the monoclonal antibody has a promising prospect in the preparation of drugs for treating tumors, resisting autoimmune diseases and the like.
    Type: Application
    Filed: January 22, 2018
    Publication date: December 3, 2020
    Inventors: Jie Zhao, Honghai Gao, Jinlin Guo, Wei Dang, Lingqiao Zhu, Chenghai Zhang, Le Zhao, Jianhe Chen, Haomin Huang, Zhenping Zhu
  • Patent number: 10738112
    Abstract: An anti-human IL-17A monoclonal antibody, the preparation method, and the use thereof are provided. The anti-human IL-17A monoclonal antibody can specifically bind to human IL-17A and has a good effect for inhibiting the secretion of inflammatory cytokines, such as IL-6 and the like by means of various cell lines induced by IL-17A, and can be used for preparing drugs for treating diseases involving immune-medicated inflammatory responses.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: August 11, 2020
    Assignee: SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
    Inventors: Chenghai Zhang, Lingqiao Zhu, Jinlin Guo, Jie Zhao, Honghai Gao, Lin Ma, Wei Dang, Yan Yang
  • Patent number: 10584176
    Abstract: The present invention relates to Fc variants having increased affinity for Fc?RIIc, methods for their generation, Fc polypeptides comprising optimized Fc variants, and methods for using optimized Fc variants.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: March 10, 2020
    Assignee: Xencor, Inc.
    Inventors: Gregory Lazar, Wei Dang, John Desjarlais, Sher Bahadur Karki, Omid Vafa, Robert Hayes
  • Patent number: 10563495
    Abstract: Disclosed herewith a separation device for performing phase separation on a three-phase liquid. The device includes: a housing; at least one pair of longitudinal baffle plates; a flow channel formed between every pair of longitudinal baffle plates; and collection chambers formed between adjacent pairs of longitudinal baffle plates. Each collection chamber is provided with a transverse baffle plate to separate the collection chamber into a first phase and a second phase collection cells. Each flow channel is provided with multiple lateral baffle plates to separate the flow channel into multiple sub-channels. In the areas of each longitudinal baffle plate where the first phase and second phase collection cells are located respectively, said longitudinal baffle plate is provided with a first and a second phase guiding holes in communication with the first phase and the second collection cells respectively.
    Type: Grant
    Filed: August 15, 2018
    Date of Patent: February 18, 2020
    Assignees: CHINA PETROLEUM & CHEMICAL CORPORATION, SINOPEC EXPLORATION & PRODUCTION RESEARCH INSTITUTE
    Inventors: Changchao Hu, Wei Dang, Xiaoxuan Xu, Zhiwei Tang, Lili Wang, Wenjie Tan, Pengyuan Ding, Caixia Bi, Youlin Zheng
  • Publication number: 20190161544
    Abstract: An anti-human IL-17A monoclonal antibody, the preparation method, and the use thereof are provided. The anti-human IL-17A monoclonal antibody can specifically bind to human IL-17A and has a good effect for inhibiting the secretion of inflammatory cytokines, such as IL-6 and the like by means of various cell lines induced by IL-17A, and can be used for preparing drugs for treating diseases involving immune-medicated inflammatory responses.
    Type: Application
    Filed: June 9, 2017
    Publication date: May 30, 2019
    Inventors: Chenghai ZHANG, Lingqiao ZHU, Jinlin GUO, Jie ZHAO, Honghai GAO, Lin MA, Wei DANG, Yan YANG
  • Publication number: 20190071512
    Abstract: The present invention relates to Fc variants having increased affinity for Fc?RIIc, methods for their generation, Fc polypeptides comprising optimized Fc variants, and methods for using optimized Fc variants.
    Type: Application
    Filed: September 21, 2018
    Publication date: March 7, 2019
    Inventors: Gregory Lazar, Wei Dang, John Desjarlais, Sher Bahadur Karki, Omid Vafa, Robert Hayes
  • Publication number: 20190055829
    Abstract: Disclosed herewith a separation device for performing phase separation on a three-phase liquid. The device includes: a housing; at least one pair of longitudinal baffle plates; a flow channel formed between every pair of longitudinal baffle plates; and collection chambers formed between adjacent pairs of longitudinal baffle plates. Each collection chamber is provided with a transverse baffle plate to separate the collection chamber into a first phase and a second phase collection cells. Each flow channel is provided with multiple lateral baffle plates to separate the flow channel into multiple sub-channels. In the areas of each longitudinal baffle plate where the first phase and second phase collection cells are located respectively, said longitudinal baffle plate is provided with a first and a second phase guiding holes in communication with the first phase and the second collection cells respectively.
    Type: Application
    Filed: August 15, 2018
    Publication date: February 21, 2019
    Applicants: China Petroleum & Chemical Corporation, Sinopec Exploration & Production Research Institue
    Inventors: Changchao Hu, Wei Dang, Xiaoxuan Xu, Zhiwei Tang, Lili Wang, Wenjie Tan, Pengyuan Ding, Caixia Bi, Youlin Zheng
  • Patent number: 10183999
    Abstract: The present invention relates to optimized Fc variants, methods for their generation, and antibodies and Fc fusions comprising optimized Fc variants.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: January 22, 2019
    Assignee: Xencor, Inc.
    Inventors: Gregory Alan Lazar, Arthur J. Chirino, Wei Dang, John Desjarlais, Stephen K. Doberstein, Robert J. Hayes, Sher Bahadur Karki, Omid Vafa
  • Patent number: 10184000
    Abstract: The present invention relates to optimized Fc variants, methods for their generation, and antibodies and Fc fusions comprising optimized Fc variants.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: January 22, 2019
    Assignee: Xencor, Inc.
    Inventors: Gregory Alan Lazar, Arthur J. Chirino, Wei Dang, John Desjarlais, Stephen K. Doberstein, Robert J. Hayes, Sher Bahadur Karki, Omid Vafa